Abstract A PubMed literature research was undertaken by t h e a u t h o r u s i n g v a r i o u s M e S H t e r m s :
Introduction
Dentin hypersensitivity (DH) is a recognized clinical condition that has been extensively reported on in the published literature particularly in the last 30 years, and yet there appears to be unresolved issues that still perplexed both the clinician and researcher. For example, overall prevalence figures from questionnaire studies rely on the patients' perception of DH which may overestimate the extent of the problem. This may be due, in part, to the patient's difficulty in determining the type of dental pain they may be experiencing at the time. According to Orchardson and Gillam [1] , however, patients who complain of DH generally have lower prevalence values (15-30 %) following a clinical examination compared to those values recorded by questionnaire alone. A further question that has been recently addressed in the literature is the extent of the impact of DH on the quality of life of those who suffer with the condition [2, 3, 4•, 5] . The question as to whether DH is a major problem for public health would however appear to suggest that DH is a relatively minor problem for the majority of the population as the discomfort is transient (episodic) in nature [6, 7] . This may also be why some patients do not selftreat or report the problem when seeing a clinician [8••] , although for at least 10 % of the general population, DH may be considered to be a severe problem which may impact on their quality of life [9] . There are, however, a number of diagnostic challenges faced by the busy clinician when examining patients complaining of dental pain in general and more specifically with DH [7] ; for example, (1) Is the prevalence of DH under or overestimated by clinicians in the practice environment? (2) Is the condition adequately diagnosed and successfully managed by clinicians in daily practice? (3) Is the clinician aware of the impact of DH on the quality of life (QOL) of their patients? (4) Is the condition adequately monitored by clinicians in daily practice? It would however appear that clinicians do not routinely screen/examine their patients for DH unless the patient prompts them [7] . There may also be a concern as to whether the clinician is confident in treating DH in daily practice particularly with the vast array of commercially available in-office and over-the-counter (OTC) that claim to be effective in reducing DH [10, 11] . Furthermore, it may also be difficult for the clinician to effectively monitor DH in a busy dental practice and any guidelines that are produced to facilitate a treatment or management paradigm need to be simple and pragmatic in nature in order for the strategy to be implemented [8••] . The aim of this review is, therefore, to update the clinician on the issues and challenges associated with the clinical management of dentin hypersensitivity and provide the clinician with simple guidelines on how to successfully manage the condition within the clinical environment.
Terminology
A number of other terms have been previously used in the published literature to describe dentin hypersensitivity (DH), for example, cervical dentin sensitivity (CDS), or cervical dentin hypersensitivity (CDH), or dentin sensitivity (DS), and more recently DHS. Although the term Bdentin hypersensitivity^(DH) has been preferred in the published literature due in part to its historical significance [12] , Bdentin sensitivity^(DS) may be a more accurate term. DH has been defined as Bpain derived from exposed dentin in response to chemical, thermal tactile, or osmotic stimuli which cannot be explained as arising from any other dental defect or disease [ 10, 12] . It is important therefore for the clinician to recognize that the definition of DH is essentially a diagnosis of exclusion. Although DH has been historically linked to individuals with relatively clean mouth, more recently, the term root sensitivity or root dentin sensitivity (RDS) or root dentin hypersensitivity (RDH) has been used to describe tooth sensitivity arising from periodontal disease and its treatment [13] [14] [15] . Most published studies, however, do not distinguish these two groups when undertaking prevalence studies.
Prevalence
One of the problems when evaluating the evidence of the true prevalence of DH is that these figures vary depending on how the data was collected or where the studies took place (e.g. questionnaire (patient/clinician based), surveys, or clinical examination; general practice, university hospital, or consumer based), and these may range form 1 to 74 % [15] . It is therefore apparent that a more universally accepted methodology (in terms of consistency and reproducibility) should be implemented by investigators when investigating the prevalence of DH in these disparate population groups. A recent review on the burden of DH by Cunha-Cruz and Wataha [16] based on the evidence of prevalence studies in the published literature would appear to suggest that the best overall estimate of the prevalence of DH in the population was 10 %.
Mechanisms Involved in Dentin Hypersensitivity
Although there have been a number of suggested mechanisms of the transmission of stimuli (e.g. cold, heat, sweet, etc.) across the dentin to the pulp, the currently held view is that the process is mediated through a hydrodynamic mechanism as proposed by Brännström and Åström [17] . However, not all stimulus transmission across the dentin can be explained by the hydrodynamic theory, and as such, there may be alternative mechanisms involved [18, 19] . According to Narhi et al. [20] , the intradental nerve fibers associated with DH are A nerve fibers (A-β and A-δ) in nature and probably activated by a hydrodynamic mechanism which may be dependent on whether the dentin tubules are open or blocked. Generally speaking, DH is differentiated from other associated tooth pain by A-δ fibers which are mainly stimulated by the application of a cold stimulus, producing sharp pain, compared to the stimulation of C fibers which produce dull aching pain [21, 22] . The question of the role of pulpal inflammation (where chemically C fibers may be involved) in DH, however, is still relatively unclear and somewhat controversial [23] . Furthermore, following more recent evidence in the published literature, the role of the odontoblast in DH, often dismissed as an irrelevant mechanism in some text books, may also need to be reappraised [24] .
Etiology and Predisposing Features
According to Gillam and Orchardson [15] , a number of etiological and predisposing factors have been identified that have been implicated in the initiation of DH, for example, abrasion, abfraction, erosion, gingival recession, quality of the buccal bone, periodontal disease and its treatment, surgical and restorative procedures, and patient destructive habits. More recently, DH has also been considered to be a toothwear phenomenon characterized predominantly by erosion, which may expose the dentin surface and initiate the tooth wear lesions [12, 25] . This concept has been supported by a number of studies that have reported on the prevalence (and risk factors) of DH associated with aspects of toothwear, for example, erosion, non-carious cervical lesions (NCCL), incisal/occlusal wear toothbrushing, and gingival recession [26, 27••, 28-30] . According to Dababneh et al. [23] , there are two specific biological processes thought to be implicated in DH, namely (1) lesion localization and (2) lesion initiation associated with the above-mentioned etiological factors. It is postulated that (1) the dentin has to be exposed as a result of the loss of enamel and/or soft tissue loss associated with gingival recession (including the loss of the cementum) (lesion localization). Secondly, once the dentin has been exposed, the patent dentin tubules will be open to the oral environment (lesion initiation) and as a consequence, any subsequent stimuli (e.g. cold) may initiate minute fluid movement within the dentin tubules, activating the mechanoreceptors in the inner third of the dentin.
One of the controversies that have arisen is the role of plaque in the etiology of DH which has divided opinion between investigators; for example, several investigators [31] [32] [33] [34] have claimed that DH is as a result of Bzealousp laque control in a healthy mouth which affects mainly the buccal surfaces of the teeth, whereas other investigators such as Bissida et al. [35] have suggested that the condition may arise as a result of periodontal disease or poor oral hygiene due to acid metabolites from bacteria that subsequently open the dentin tubules. Wang et al. [36] however did not observe any relationship between plaque and DH whereas Addy et al. [34] showed a correlation between plaque score and DH. It may therefore be suggested that these two opposing philosophies may simply be different manifestations of the same clinical problem although there is no substantive evidence in the published literature to support this suggestion. More recently the Broot sensitivity^(RS) was suggested by the European Federation of Periodontology [13] to describe tooth sensitivity associated with periodontal disease and/or periodontal therapy and by definition would consider RS to be a different condition compared to DH in so-called clean mouths.
Clinical Features of DH
According to Gillam et al. [8••] , the teeth that have been identified to be commonly associated with DH are canines, premolars, and molars with the buccal aspect of the tooth more frequently exposed as a result of overzealous and/or incorrect toothbrushing in association with other etiological factors. It is important however to acknowledge that there may be different precipitating and predisposing factors associated with DH, and these features should be carefully considered when deciding on a management strategy for treating DH. For example, according to Gillam et al. [8••] , patients can be categorized as follows: patients (1) who have relatively healthy mouths and DH as a result of meticulous and perhaps overzealous oral hygiene, (2) who complain of DH as a result of periodontal disease and/or its treatment and may also have esthetic concerns relating to the loss of gingival tissue (gingival recession) and (3) who complain of DH as a result of toothwear problems. This management strategy may therefore help the clinician address the different presenting features associated with DH with a more tailored approach than simply following a non-specific generalized management strategy.
Clinical Diagnosis of DH (Including Differential Diagnosis)
According to Gillam [7] , clinicians should therefore be made aware not only of the importance of identifying patients with DH but also of the relevance of a correct diagnosis that may exclude any confounding factors from other oro-facial pain conditions prior to the successful management of the condition. Several investigators, however, have reported on the difficulties that clinicians have faced when treating the condition, and it is clear that there is a need to recommend practical guidelines that may be implemented into a busy clinical practice [8••, 11] . It should also be acknowledged that the treatment and management of DH is generally considered difficult due to the highly subjective nature of the pain response and the variation of this response between individuals. Furthermore, it is essential that before any treatment is undertaken, a definitive diagnosis has been reached, and this involves as indicated by the definition of DH the exclusion of all other oral conditions with a similar presentation to that of DH (Fig. 1) .
In order to determine a definitive diagnosis, it is important for the clinician to record a thorough history of the patient's complaint and this should include an assessment of the extent and severity of the problem. A number of methodological measures have been proposed to both qualify and quantify the pain associated with DH, and these include both mechanical and thermal stimulation of the exposed dentin in order to elicit a response from the patient [37] . The so-called subjective response from the patient may also be recorded by a variety of accepted pain scales, for example, visual analog score scales (VAS), Schiff Cold Air Sensitivity Scale, verbal descriptors, and numerical scoring scales (e.g. 0-10) [37] . From the clinician's perspective, the use of an explorer probe and an air blast from a triple air syringe together with an indication of the degree of discomfort from the patient following the application of the stimulus during the clinical examination may be acceptable for both the identification of susceptible sites and the severity of the pain response. When conducting clinical trials, however, more specialized devices are employed, for example, controlled pressure probes (Yeaple and Jay [Sensitivity Sensor] probes) [37] [38] [39] , thermal probes, and standardized pain stimulation techniques using triple air syringe [37, 40] . The patient's subjective pain response following the application of these stimuli include the above-mentioned pain scales, and more recently, quality of life measures have also been included [2, 3, 4•, 5] . Several investigators however have criticized the methodology employed in the clinical trial environment due to the variability, lack of consistency, and reproducibility of the various stimuli used in the assessment [37, 40, 41] . Furthermore, the lack of patient/person-based outcomes in clinical trials that evaluate the efficacy of desensitizing products needs to be addressed [42] .
Clinical Management of Dentin Hypersensitivity
There have been a number of treatment paradigms recommended in the literature relating to the management of DH [1, 10, 43] . One of the problems however with these paradigms
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CASE HISTORY
History of patient's complaint Review patient's dental & medical history.
NO TREATMENT REQUIRED
CLINICAL EXAMINATION
Examine dentition to exclude other causes for example: · Cracked tooth syndrome · Post-restorative sensitivity · Fractured restorations · Marginal leakage · Chipped teeth · Pulpitis · Dental caries · Palatogingival grooves · Gingival inflammation Use either evaporative/thermal or tactile stimuli to identify sensitive areas. Record the severity of DH at sites following the application of stimulus or overall sensitivity.
RESOLUTION OF PATIENT'S COMPLAINT: NO FURTHER TREATMENT OF DH NECESSARY (at this time)
Continue to monitor any underlying conditions and, if appropriate to implement a suitable DH management in the form of professional or at-home treatments, removal of any etiological factors. • Clinical measurement of the gingival recession defect
No Yes
Yes
• Take study casts and clinical photographs to monitor condition over time
• Check and monitor periodontal health • Identification and correction of predisposing or precipitating factors
• Use of pain scores to assess and monitor DH (e.g. visual analog scores)
• Identify cause of tooth wear (enamel loss)
• Record severity of lesions, if possible, using a recognized index [66, 67] • Take study casts and clinical photographs to monitor condition over time • Check and monitor periodontal health • Use of pain scores to assess and monitor DH (e.g. visual analog scores)
• Periodontal disease or periodontal treatment as the primary cause of exposure of dentin and associated DH
• Check and monitor periodontal health (6 point pocket charting)
Patient education (including preventive advice)
• Show patient the affected site(s)
• Explain probable cause for recession • Explain factors triggering sensitive teeth episodes • Encourage patients to modify their oral hygiene regimen in order to reduce damage to gingivae (e.g. reducing brushing force, correction of toothbrush technique)
• Reduce excessive consumption of acidic foods and drinks • Show patient the site(s) and explain probable cause of the toothwear lesion(s)
• Recommend an oral hygiene regimen to minimize risk of further toothwear • Where appropriate recommend reducing frequency of consumption of acidic food and drink
• Reinforce the need for good oral hygiene • Show patient the site(s) affected by periodontal disease and explain probable cause of the exposed dentin
• Guide the patient to improve
Bat home^oral hygiene regimen was that they were difficult to implement and effectively monitor DH over time in a busy dental practice, and as such, there is a need to produce guidelines that are relatively simple and pragmatic in nature in order for the strategy to be implemented (Gillam et al. [8••] ). For example, a simple less invasive stepwise approach has been proposed by Orchardson and Gillam [1] which may be an appropriate strategy for managing DH depending of the extent and severity of DH. More recently, the UK Forum guidelines document on DH may also help clinicians to adopt a simplified management scheme which could be easier to implement into a clinical practice [8••] . It is, however, important for the clinician to recognize that one of the key components from the UK guidelines document [8••] was that no desensitizing product (OTC or professionally applied) can fully resolve the various presenting features of DH, and therefore, it may be prudent for the clinician to utilize a range of products in order to resolve the patient's symptoms (Fig. 1 , Table 1 ). The successful management of DH therefore not only involves the correct diagnosis of the condition by the clinician (which is essentially a diagnosis of exclusion) but also includes the importance of implementing prevention strategies that either eliminate or limit any further deterioration of DH by appropriate treatment choices, dietary advice, and monitoring of
The clinician has a range of both in-office (professionally applied) and over-the-counter (OTC) products which have been reported to be effective in reducing DH either through their tubular-occluding or nerve-desensitizing properties based on the principle of the hydrodynamic theory [1] . One of the problems, however, for the clinician is which of these in-office and OTC products would be effective both in the short and long term and while there have been a number of papers supporting the various claims of efficacy in reducing DH, there does not appear to be one product that would be considered the gold standard for the treatment of DH. As indicated above, it is important for the clinician to have confidence in the ability of these products to successfully treat DH; the evidence from the published literature would appear to suggest that this is not the case [11] . Furthermore, as indicated by Gillam et al. [8••] , the management of DH should not involve simply providing treatment without first removing any etiological factor associated with DH and educating the patient in reducing any future risk to the hard and soft tissues.
The clinician is somewhat reliant on the evidence in the published literature in regard to which product is more effective and while there is evidence of efficacy of these products, there are problems arising when comparing the results of the various products due to differences in study design, desensitizing products, duration, assessment methodology, etc. For example, there have been a number of published papers on OTC products containing stannous, strontium, potassium, arginine, oxalate, and hydroxyapatite ingredients and inoffice products and procedures (varnishes, sealants, glass ionomer cements, lasers) that would suggest a degree of efficacy when used to treat DH) [1, [44] [45] [46] [47] [48] [49] [50] [51] . However, a number of systematic reviews appear to give equivocal results, some positive and a number of negative reviews [52-63, 64•] . Although the consensus from these reviews appears to be that there is evidence for the various claims of efficacy for most of these in-office and OTC products, nevertheless the entire body of clinical research literature is far from being unequivocal in pronouncing one superior strategy [8••, 64•, 65] .
Conclusions
Recent proposals by a UK Expert Forum on DH [8••] would appear to provide practical, evidence-based guidance on the management of DH for the diagnosis, monitoring, prevention, and treatment of specific presenting features of patients with DH. It is also evident from the published literature that a one strategy management approach cannot fully resolve the problem for all patients with DH. The importance of educating both the clinician and the patient in the identification, prevention, and management of DH is paramount if the condition is to be successfully monitored and treated.
